Share-Based Compensation (Tables)

6 Months Ended

Aug. 01, 2026

Share-Based Payment Arrangement [Abstract]

Stock Option Activity Under Stock Option Plan

The following table summarizes stock option activity for the twenty-six weeks ended August 1, 2026 (aggregate intrinsic value in thousands):


	Stock Options	Grant Date Weighted Average Exercise Price		Weighted Average Remaining Contractual Life (in Years)	Aggregate Intrinsic Value (1)
Outstanding at January 31, 2026	4,125,458	$	4.64
Granted	511,000	$	4.23
Exercised	(36,375)	$	3.21
Forfeited	(85,500)	$	5.07
Expired	(81,093)	$	9.12
Outstanding at August 1, 2026	4,433,490	$	4.52	7.8	$	3,969
Exercisable at August 1, 2026	1,489,365	$	7.99	5.4	$	153

(1)Intrinsic value for stock options is defined as the difference between the market price of our Class A common stock on the last business day of the fiscal period and the weighted average exercise price of in-the-money stock options outstanding at the end of the fiscal period. The market value per share was $3.81 at August 1, 2026.

Assumptions Used to Estimate Fair Value of Stock Options Granted

The fair values of stock options and performance-based stock options granted during the thirteen and twenty-six weeks ended August 1, 2026 and August 2, 2025 were estimated on the grant date using the following assumptions:


	Thirteen Weeks Ended						Twenty-Six Weeks Ended
	August 1, 2026			August 2, 2025			August 1, 2026			August 2, 2025
Weighted average grant-date fair value per option granted	$	3.27		$	—		$	2.59		$	1.20
Expected option term (1)	5.7 years			—			5.7 years			5.4 years
Weighted average expected volatility factor (2)	66.4		%	—		%	65.1		%	57.0		%
Weighted average risk-free interest rate (3)	4.3		%	—		%	4.0		%	4.0		%
Expected annual dividend yield (4)	—		%	—		%	—		%	—		%

(1)The expected option term of the awards represents the estimated time that options are expected to be outstanding based upon historical option data.

(2)Stock volatility for each grant is measured using the historical daily price changes of our common stock over the most recent period equal to the expected option term of the awards.

(3)The risk-free interest rate is determined using the rate on treasury securities with the same term as the expected life of the stock option as of the grant date.

(4)We do not currently have a dividend policy, and we do not currently anticipate paying any cash dividends on our common stock at this time.

Summary of Status of Non-Vested Restricted Stock

The following table summarizes the status of non-vested restricted stock as of August 1, 2026, and the changes since January 31, 2026:


	Restricted Stock	Weighted Average Grant-Date Fair Value
Nonvested at January 31, 2026	358,462	$	1.56
Granted	77,220	5.18
Vested	(194,527)	1.85

Nonvested at August 1, 2026	241,155	$	2.49

Schedule of Stock Based Compensation

The following table summarizes share-based compensation expense recorded in the Consolidated Statements of Operations (in thousands):


	Thirteen Weeks Ended				Twenty-Six Weeks Ended
	August 1, 2026		August 2, 2025		August 1, 2026		August 2, 2025
Cost of goods sold	$	94	$	85	$	176	$	153
Selling, general, and administrative	581		294		1,001		666
Total share-based compensation	$	675	$	379	$	1,177	$	819